AngioDynamics, Inc. (ANGO)
NASDAQ
Key stats Fiscal year 2026
Income statement
- Revenue
- 320,174,000 9.5%
- Net income
- -36,742,000
- Gross profit
- 174,892,000
- Operating income
- -39,927,000
- Earnings per share
- -0.88
- R&D expense
- 29,447,000
Growth and profitability
- Gross margin
- 54.62
- Operating margin
- -12.47
- Net margin
- -11.48
- Return on equity
- -21.51
- Return on assets
- -13.75
- Free cash flow margin
- 0.16
Balance sheet
- Total assets
- 267,163,000
- Total liabilities
- 96,338,000
- Shareholders' equity
- 170,825,000
- Cash and equivalents
- 53,864,000
- Current ratio
- 2.19
Cash flow and ratios
- Operating cash flow
- 3,089,000
- Free cash flow
- 508,000
Shareholder returns
- Share buybacks
- 0
- Shares outstanding
- 42,054,450
- Book value per share
- 4.06
Company information
- Headquarters
- Latham, NY
- Exchange
- NASDAQ
- Fiscal year end
- 05-31
- Industry (SEC)
- Surgical & Medical Instruments & Apparatus
Fiscal year end: · Source: SEC EDGAR
AngioDynamics, Inc. trades on NASDAQ under the ticker symbol ANGO. This page brings together its price chart, company profile, key financial figures and technical indicators.